Sharemaestro company-news research for Medtronic plc (MDT), showing current tone, evidence confidence, direct company coverage, sector and industry context, completed price response and the source headlines used on the page. Scores describe published news evidence. Confidence describes the amount, freshness, source breadth and direct company relevance of that evidence. Price context is shown separately.

VIE Austria Provisional evidence

Company news sentiment

MDT news sentiment

Medtronic plc

Company headlines from the last 30 days, weighted by freshness, relevance, publisher quality and the strength of the wording. Price is shown separately.

Full chart Weekly report RSS feed
30-day score57Neutral is 50
Early balanced news score 32/100 evidence confidence 88% direct company focus 16 current stories across 10 publishers
Latest weekly closeEUR 74.56week of 7 Aug 2026
Main news subjectMarket update78/100 share of current news
News data statusHealthy2 duplicate stories removed

Current company news

Early balanced news score

16 company-specific stories are available, but there are not yet enough fresh stories from separate publishers for a firm reading.

Observed headline tone68/100 Published 30-day score57/100

Older, less relevant and less reliable stories count for less. Confidence is shown separately.

Latest source headline Revisiting Former Stock Picks Medtronic, Quantas Services, Lennar finance.yahoo.com · 13 Aug 2026 04:43

What supports the score

Direct evidence

16 current stories are mapped specifically to MDT.

Source breadth

The score uses 10 publishers rather than depending on one outlet.

What limits the score

Too little evidence

The stories agree, but freshness-weighted evidence is only 0.524.

Confidence

Confidence is 32/100, below the threshold for a firm score.

57/100
News scoreEarly balanced news score
32/100
Confidencethin evidence
88%/100
Company news16 company stories
83/100
Story agreement17/100 difference

News history

Daily score and story count over 30 days

Daily weighted evidence
15 Jul: 1 stories16 Jul: 1 stories18 Jul: 1 stories20 Jul: 1 stories22 Jul: 1 stories24 Jul: 1 stories26 Jul: 1 stories28 Jul: 1 stories31 Jul: 1 stories04 Aug: 1 stories08 Aug: 2 stories09 Aug: 1 stories11 Aug: 1 stories12 Aug: 1 stories13 Aug: 1 stories 15 Jul: tone 50, 1 stories16 Jul: tone 50, 1 stories18 Jul: tone 50, 1 stories20 Jul: tone 50, 1 stories22 Jul: tone 42, 1 stories24 Jul: tone 50, 1 stories26 Jul: tone 50, 1 stories28 Jul: tone 35, 1 stories31 Jul: tone 42, 1 stories04 Aug: tone 50, 1 stories08 Aug: tone 50, 2 stories09 Aug: tone 85, 1 stories11 Aug: tone 71, 1 stories12 Aug: tone 57, 1 stories13 Aug: tone 50, 1 stories 95505
15 Jul30 Jul13 Aug
News scoreStory count50 baseline

Confidence

How reliable the score is

Separate from direction

Confidence uses the amount of news, separate publishers, direct company relevance, freshness and agreement. A high or low score is not automatically reliable.

Amount of evidence10
0.524 after freshness weighting
Source breadth100
10 independent publishers
Company relevance88
share tied directly to this company
Freshness55
recency-weighted evidence
Agreement83
how closely stories agree
Publisher mix28
less reliance on one publisher

Price and news history

News score and weekly price over 26 weeks

Early company-news score

Company-specific news is present, but the evidence has not yet earned enough independent, fresh information weight for price confirmation to be treated as a firm signal.

One scoring method across the chart.Stored company headlines are recalculated at each weekly point with the current 30-day freshness weighting. Old published snapshots are left unchanged.
13 Feb 2026: close 84.45, indexed 100.020 Feb 2026: close 81.93, indexed 97.027 Feb 2026: close 81.59, indexed 96.606 Mar 2026: close 77.89, indexed 92.213 Mar 2026: close 75.71, indexed 89.720 Mar 2026: close 74.28, indexed 88.027 Mar 2026: close 75.72, indexed 89.703 Apr 2026: close 74.9, indexed 88.710 Apr 2026: close 74.56, indexed 88.317 Apr 2026: close 73.36, indexed 86.924 Apr 2026: close 70.07, indexed 83.001 May 2026: close 67.55, indexed 80.008 May 2026: close 64.72, indexed 76.615 May 2026: close 65.16, indexed 77.222 May 2026: close 66.96, indexed 79.329 May 2026: close 63.35, indexed 75.005 Jun 2026: close 70.52, indexed 83.512 Jun 2026: close 68.5, indexed 81.119 Jun 2026: close 68.5, indexed 81.126 Jun 2026: close 71.64, indexed 84.803 Jul 2026: close 72.02, indexed 85.310 Jul 2026: close 72.72, indexed 86.117 Jul 2026: close 73.18, indexed 86.724 Jul 2026: close 73.28, indexed 86.831 Jul 2026: close 73.52, indexed 87.107 Aug 2026: close 74.56, indexed 88.3 26 Jun 2026: news score 50, close 71.64, 3 stories5003 Jul 2026: news score 50, close 72.02, 8 stories5010 Jul 2026: news score 51, close 72.72, 13 stories5117 Jul 2026: news score 50, close 73.18, 16 stories5024 Jul 2026: news score 50, close 73.28, 18 stories5031 Jul 2026: news score 48, close 73.52, 17 stories4807 Aug 2026: news score 49, close 74.56, 15 stories49
13 Feb15 May07 Aug
Weekly close, indexedSentiment score
26-week price-11.7%latest close 74.56
News score change-1first to latest comparable week
One-week response+1.4%Price digesting
Fair-value position+0.6%Near fair-value range
WeekNews scoreCloseWeekly move
07 Aug 202649EUR 74.56+1.4%
31 Jul 202648EUR 73.52+0.3%
24 Jul 202650EUR 73.28+0.1%
17 Jul 202650EUR 73.18+0.6%
10 Jul 202651EUR 72.72+1.0%
03 Jul 202650EUR 72.02+0.5%
26 Jun 202650EUR 71.64+4.6%
Provisional evidence

News subjects

What is shaping the score

Market update
Market update508 stories · 50%
Earnings726 stories · 38%
Regulatory and legal351 stories · 6%
Capital return501 stories · 6%

Source mix

Where the evidence comes from

28/100 independence
finance.yahoo.com725 stories · 31%
Market source362 stories · 12%
Kavout | AI502 stories · 12%
MarketWatch421 stories · 6%
simplywall.st421 stories · 6%
nasdaq.com501 stories · 6%
Seeking Alpha501 stories · 6%

Recurring subjects

Subjects appearing most often

Current evidence
Share Price3Earnings3Revenue Growth2Healthcare2Dividends2Valuation1Upgrade Downgrade1Shareholder1Quarterly Results1Medtech1

Earlier readings

How the score has changed

30 comparable readings · 53 days
Past and present use the same method.Each point recalculates the previous 30 days of stored company headlines with today's scoring rules. The original stored snapshots remain unchanged.
Comparable move+650 to 56 · Strengthening
Observed range48–5650 is the neutral baseline
Evidence depth19stories at latest stored reading · +18
Confidence29/100Provisional · +3
21 Jun50 neutral13 Aug 20:31
ConstructiveBalanced or withheldCautious

Changes in the stored score

Scores are rebuilt from stored headlines with the current 30-day method. Days with no change are collapsed.

ObservedScoreMoveConfidenceStoriesStatus
13 Aug 20:3156+029/100 (-2)19 (+1)Provisional
12 Aug 23:5956+031/100 (-1)18 (+1)Provisional
11 Aug 23:5956+032/100 (-2)17 (+1)Provisional
09 Aug 23:5956+734/100 (+8)16 (0)Provisional
08 Aug 23:5949+026/100 (+4)16 (+1)Provisional
07 Aug 23:5949+022/100 (-2)15 (-1)Provisional
04 Aug 23:5949+024/100 (-1)16 (0)Provisional
02 Aug 23:5949+125/100 (-2)16 (-1)Provisional

Source headlines

The news behind the score

Showing 1-16 of 16

Only company-specific stories enter this score. The latest 30 days are shown newest first, with newer stories weighted more heavily and duplicate coverage combined.

#150Tone
finance.yahoo.comDirect company coverage

Revisiting Former Stock Picks Medtronic, Quantas Services, Lennar

Reassessing stock picks is one of the best habits an investor can build. Watch Doug discuss recent stock picks, provide input on the current market environment—and take your questions. The daily chart illustrates how well the stock has performed relative to its peers on the ratio chart against the over the past two months. Continue Reading

Published
13 Aug 2026 04:43
News subject
Market update
Why this score
No clear positive or negative phrase
Company focus
Shared story · 78%
How it is used
Direct company coverage
Weighted influence
Low · 6.2% · 0.7d old
Duplicates
1 consolidated
#257Tone
finance.yahoo.comDirect company coverage

Does Medtronic (MDT) Still Trade At A Discount After Its CE Mark Win?

Find your next quality investment with Simply Wall St's easy and powerful screener, trusted by over 7 million individual investors worldwide. Medtronic stock has delivered a 20.8% gain over the past three years, yet current checks suggest it now sits close to its estimated intrinsic value rather than at a clear discount. At the same time, earnings-based multiples still screen the shares as undervalued, which sets up a debate over how much upside is left from here. A 20.8% return over three years points to steady value creation for Medtronic shareholders, not a rapid rerating. Progress in highe

EarningsFree Cash FlowIntrinsic ValueMedical EquipmentShare PriceValuation
Published
12 Aug 2026 02:35
News subject
Earnings
Why this score
Positive financial language
Company focus
Shared story · 78%
How it is used
Direct company coverage
Weighted influence
Medium · 13% · 1.8d old
Duplicates
1 consolidated
#371Tone
finance.yahoo.comDirect company coverage

Medtronic (MDT) Wins Analyst Upgrades, Is It Fully Priced?

Find your next quality investment with Simply Wall St's easy and powerful screener, trusted by over 7 million individual investors worldwide. Medtronic (MDT) has moved back into focus after multiple analyst upgrades tied to what they describe as the company's strongest annual revenue growth in a decade, supported by its cardiac portfolio and new product launches. See our latest analysis for Medtronic. Over the past quarter Medtronic has picked up momentum, with a 90 day share price return of 16.39% and a 30 day gain of 6.61%, while the 1 year total shareholder return is close to flat and the 5

Analyst UpgradesDividendsHealthcareRevenue GrowthShare PriceShareholder
Published
11 Aug 2026 19:15
News subject
Earnings
Why this score
Operating growth
Company focus
Shared story · 78%
How it is used
Direct company coverage
Weighted influence
High · 21% · 2.1d old
Duplicates
1 consolidated
#485Tone
finance.yahoo.comDirect company coverage

Is Medtronic (MDT) Becoming a Turnaround Story?

UBS upgraded Medtronic (NYSE:MDT) to a Buy from Neutral today, telling investors in a research note that a "turnaround" is underway at the company. The upgrade raises an important question for investors: Is Medtronic finally returning to sustainable growth after years of underperformance, or is it too early to call the turnaround complete?Truist Maintains Hold on Medtronic (MDT), Seeks Stronger EPS Growth Bull case One of the most prominent factors supporting Medtronic's (NYSE:MDT) turnaround story is the company's reporting of its highest annual revenue growth in 10 years in its fiscal Q4 and

CardiovascularEarningsM AMedtechRevenue GrowthUpgrade Downgrade
Published
09 Aug 2026 23:43
News subject
Earnings
Why this score
Analyst upgrade, Operating growth
Company focus
Main company · 100%
How it is used
Direct company coverage
Weighted influence
High · 38.8% · 3.9d old
Duplicates
1 consolidated
#550Tone
nasdaq.comDirect company coverage

Medtronic vs. Intuitive Surgical: Which MedTech Stock Is the Better Buy Right Now?

Key Points Medtronic has launched new devices that will help further improve its financial results. Intuitive Surgical's latest da Vinci system could expand its addressable market. Each stock will appeal to investors with different priorities. 10 stocks we like better than Medtronic › Medtronic(NYSE: MDT) and Intuitive Surgical(NASDAQ: ISRG), two medical device leaders, haven't performed well this year. While weakness in the broader healthcare sector hasn't helped, they have both encountered company-specific issues that have contributed to their lagging the market. The good news is that there

CompetitionDividendsEarningsEarnings GrowthEarnings Per ShareEarnings Release
Published
08 Aug 2026 21:20
News subject
Earnings
Why this score
No clear positive or negative phrase
Company focus
Shared story · 78%
How it is used
Direct company coverage
Weighted influence
Low · 6.6% · 5.0d old
Duplicates
2 consolidated
#650Tone
finance.yahoo.comDirect company coverage

Medtronic (MDT) Wins Expanded CE Mark For Affera System In Ventricular Arrhythmias

Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St. Medtronic (NYSE:MDT) receives expanded CE Mark indication for its Affera Mapping and Ablation System and Sphere-9 Catheter for ventricular arrhythmia treatment. The Sphere-9 catheter also holds a Breakthrough Device Designation from the U.S. FDA, which highlights its potential clinical impact. This broader regulatory progress could influence Medtronic's position in cardiac arrhythmia care across international markets. As cardiac care technology evolves and Medtronic advances

Cardiac CareHealthcareMedical DevicesQuarterly ResultsShare Price
Published
08 Aug 2026 02:09
News subject
Earnings
Why this score
No clear positive or negative phrase
Company focus
Shared story · 78%
How it is used
Direct company coverage
Weighted influence
Low · 5.5% · 5.8d old
Duplicates
1 consolidated
#750Tone
Market sourceDirect company coverageScored from headlineSource lookup

Medtronic (MDT) Laps the Stock Market: Here's Why

Published
04 Aug 2026 13:29
News subject
Market update
Why this score
No clear positive or negative phrase
Company focus
Main company · 100%
How it is used
Direct company coverage
Weighted influence
Low · 0.4% · 9.3d old
Duplicates
1 consolidated
#842Tone
MarketWatchDirect company coverageScored from headlineSource lookup

Medtronic PLC stock outperforms competitors despite losses on the day

Published
31 Jul 2026 02:19
News subject
Market update
Why this score
Negative financial language
Company focus
Main company · 100%
How it is used
Direct company coverage
Weighted influence
Low · 0.2% · 13.8d old
Duplicates
1 consolidated
#935Tone
Market sourceDirect company coverageScored from headlineSource lookup

Is Medtronic (MDT) Fairly Valued After Its Pediatric Cannula Recall?

Published
28 Jul 2026 13:28
News subject
Regulatory and legal
Why this score
Legal or regulatory risk
Company focus
Main company · 100%
How it is used
Direct company coverage
Weighted influence
Low · 7.3% · 16.4d old
Duplicates
1 consolidated
#1050Tone
Kavout | AIDirect company coverageScored from headlineSource lookup

Is Medtronic's MiniMed Spin-Off a Smart Bet for Investors

Published
26 Jul 2026 13:19
News subject
Market update
Why this score
No clear positive or negative phrase
Company focus
Main company · 100%
How it is used
Direct company coverage
Weighted influence
Low · <0.1% · 18.4d old
Duplicates
1 consolidated
#1150Tone
Seeking AlphaDirect company coverageScored from headlineSource lookup

Intuitive Surgical, Medtronic down as J&J wins FDA nod for surgical robot

Published
24 Jul 2026 09:27
News subject
Market update
Why this score
No clear positive or negative phrase
Company focus
Main company · 100%
How it is used
Direct company coverage
Weighted influence
Low · <0.1% · 20.5d old
Duplicates
1 consolidated
#1242Tone
simplywall.stDirect company coverageScored from headlineSource lookup

Medtronic (MDT) Stock Looks Reasonable Despite Its 26% Five Year Decline

Published
22 Jul 2026 19:08
News subject
Market update
Why this score
Negative financial language
Company focus
Main company · 100%
How it is used
Direct company coverage
Weighted influence
Low · <0.1% · 22.1d old
Duplicates
1 consolidated
#1350Tone
marketscreener.comDirect company coverageScored from headlineSource lookup

Medtronic to announce financial results for its first quarter of fiscal year 2027

Published
20 Jul 2026 17:12
News subject
Earnings
Why this score
No clear positive or negative phrase
Company focus
Main company · 100%
How it is used
Direct company coverage
Weighted influence
Low · 0.6% · 24.2d old
Duplicates
1 consolidated
#1450Tone
Stock TitanDirect company coverageScored from headlineSource lookup

Medtronic Adds 60-Day Pain Therapy Without Permanent Implant

Published
18 Jul 2026 12:01
News subject
Market update
Why this score
No clear positive or negative phrase
Company focus
Main company · 100%
How it is used
Direct company coverage
Weighted influence
Low · <0.1% · 26.4d old
Duplicates
1 consolidated
#1550Tone
Kavout | AIDirect company coverageScored from headlineSource lookup

Is Medtronic Finally Poised for a Turnaround

Published
16 Jul 2026 11:09
News subject
Market update
Why this score
No clear positive or negative phrase
Company focus
Main company · 100%
How it is used
Direct company coverage
Weighted influence
Low · <0.1% · 28.4d old
Duplicates
1 consolidated
#1650Tone
ChartMillDirect company coverageScored from headlineSource lookup

Medtronic PLC (NYSE:MDT): A Top Dividend Stock for Quality and Income Investors

Published
15 Jul 2026 11:15
News subject
Capital return
Why this score
No clear positive or negative phrase
Company focus
Main company · 100%
How it is used
Direct company coverage
Weighted influence
Low · 0.3% · 29.4d old
Duplicates
1 consolidated

Earlier company news

MDT news archive

Showing 1-16 of 16 stored headlines

Stored newest first for historical research. It starts after the newest three pages above and then continues through older news. Each archive page is loaded only when it is opened.

Jul 02 2026
Quiver QuantitativeArchivedLegacy headline · tone unscoredLegacy source lookup

Why Medtronic (MDT) Stock Is Up Today

Published
2 Jul 2026 20:08
Catalyst
Legacy snapshot
Coverage
Direct company
Duplicates
1 consolidated

How the page works

How to read the score

The score shows direction

It describes the weighted balance of qualifying headlines. A score of 50 can mean balanced news or that there is not enough evidence; the status label explains which.

Confidence is separate

Confidence measures depth, source breadth, direct relevance, freshness and agreement. It does not rise merely because the tone is extreme.

Price is confirmation

Weekly price response, trend and fair-value position test whether the market is accepting or rejecting the news. They never rewrite the news score.

What the page does

It measures news already published. It is not a forecast, recommendation or price target.

Evidence context